Status:
COMPLETED
Facial Palsy Treatment
Lead Sponsor:
Hamad Medical Corporation
Conditions:
Facial Palsy
Stroke Rehabilitation
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
The Primary objective of the study is to investigate the most effective treatment modalities available to speech language pathologist as well as movement difference by comparing them.
Eligibility Criteria
Inclusion
- Patients with 1st stroke
- Hemorrhagic stroke
- Ischemic stroke
- Right hemispheric stroke
- Left hemispheric stroke
- Normal cognitive skills (Based on Montreal cognitive assessment MOCA)
- Normal Language (Not Aphasic)
- Normal swallowing
Exclusion
- Patients with Bell's palsy
- Facial trauma
- Post otitis media surgeries
- Neoplasm, malignant or tumor cell invasion of facial nerve
- Cognitive impairment
- Patients with aphasia
- Patients on defibrillator cardiac devices
- Patients with pacemakers or any other type of cardiac devices
- Multiple strokes
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 29 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06976814
Start Date
April 19 2021
End Date
June 29 2022
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamad Medical Corporation
Doha, Qatar, Qatar, 3050